Table 1

 Five year relative and observed survival in patients diagnosed and undergoing surgery in 1993–9 (n = 2144)

No of patientsSurvival95% CI of relative survival
Observed (%)Relative (%)
CI, confidence interval; VATS, video assisted thoracic surgery.
Total214440.646.444.0 to 48.8
Sex
    Female74151.755.851.9 to 59.7
    Male140334.841.038.1 to 43.9
Age (years)
    <5021755.255.949.2 to 62.6
    50–5942146.247.943.0 to 52.8
    60–6977541.145.541.6 to 49.4
    70–7968733.242.938.4 to 47.4
    80–894422.741.618.9 to 64.3
Side
    Left96641.547.443.9 to 50.9
    Right117839.945.642.5 to 48.7
Surgical procedure
    Upper lobectomy70248.855.651.5 to 59.7
    Middle lobectomy6053.361.847.1 to 76.5
    Lower lobectomy47344.051.346.0 to 56.6
    Bilobectomy20243.149.241.4 to 57.0
    Pneumonectomy58926.329.525.6 to 33.4
    Sublobar resection11839.046.335.9 to 56.7
Surgical technique
    Open thoracotomy208940.446.243.8 to 48.6
    VATS5547.354.239.1 to 69.3
Resection margin
    Free199342.048.045.5 to 50.5
    Involved14223.226.218.4 to 34.0
    Possibly involved or not described911.113.70.0 to 39.0
Histopathology type
    Squamous cell80437.944.540.6 to 48.4
    Adenocarcinoma78336.140.737.0 to 44.4
    Bronchioloalveolar7259.768.055.1 to 80.9
    Carcinoid10294.199.094.1 to 103.9
    Small cell3342.449.329.7 to 68.9
    Large cell15036.741.532.7 to 50.3
    Other20037.542.735.1 to 50.3
pStage
    I137550.858.455.3 to 61.5
    Ia55963.571.967.4 to 76.4
    Ib81642.148.945.0 to 52.8
    II53225.128.424.3 to 32.5
    IIa12228.732.023.0 to 41.0
    IIb41024.027.422.7 to 32.1
    III19615.817.912.0 to 23.8
    IIIa13313.515.18.6 to 21.6
    IIIb6320.624.112.5 to 35.7
    IV4119.521.18.0 to 34.2
Hospital volume
    <2086941.547.844.1 to 51.5
    ⩾20127440.045.542.3 to 48.5
Tumour size (cm)
    ⩽385751.658.354.6 to 62.0
    >3–571037.843.739.6 to 47.8
    >549825.128.924.6 to 33.2
    Unknown7944.349.937.6 to 62.2